GELSYN-3
-
Biologics
Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans
September 09, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has agreed to a nationwide contract with UnitedHealthcare…
Read More » -
Biologics
Bioventus Launches GELSYN-3™ for Treatment of Knee Osteoarthritis Pain
DURHAM, N.C.–(BUSINESS WIRE)– August 9, 2016 Bioventus, a global leader in orthobiologic solutions, today announced it has launched GELSYN-3™, a…
Read More »